SCHEMBL29796907

SCHEMBL29796907

CC(C)(C)OC(=O)N[C@H]1CSc2cc(F)c(-c3nnc(NC4CN(C(=O)OCC5c6ccccc6-c6ccccc65)CC(F)(F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961855 1.00 — —
SCHEMBL26961756 0.89 THRB (0.32) —
SCHEMBL29796830 0.85 P2RX3 (0.33) —
SCHEMBL26961909 0.85 P2RX3 (0.33) —
SCHEMBL29796933 0.83 SRC (0.33) —
SCHEMBL26962006 0.83 SRC (0.33) —
SCHEMBL26961941 0.80 FPR2 (0.30) —
SCHEMBL26962091 0.80 P2RX3 (0.34) —
SCHEMBL26961847 0.79 POLB (0.34) —
SCHEMBL26962041 0.79 POLB (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
WO-2022171745-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2022-08-18 — — WO disclosed
Send feedback